From: Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study
Inclusion criteria: |
• Trial assessed an intervention for efficacy in the treatment or prevention of COVID-19 infection and subsequent acute disease.a |
• Trial included a completion date, or primary completion date, on or before 30 June 2021 |
Exclusion criteria: |
• Registration was found, at any time, to indicate that the trial was withdrawn before enrollment and therefore never occurred |
• Registration prior to 1 January 2020 |
• Trial exclusively on symptomatic treatment of COVID-19 disease side-effects only (post hoc) |
• Trial on rehabilitation after acute disease or treatment of post-COVID-19 disease (post hoc) |